Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-25-000865
Filing Date
2025-01-10
Accepted
2025-01-10 16:50:26
Documents
5
Effectiveness Date
2025-01-10
Reference 429
333-239186

Document Format Files

Seq Description Document Type Size
1 FORM S-8 pbla20250109_s8.htm S-8 37452
2 EXHIBIT 5.1 ex_764055.htm EX-5.1 9921
3 EXHIBIT 23.1 ex_764056.htm EX-23.1 2744
4 EXHIBIT FILING FEES ex_764057.htm EX-FILING FEES 16308
5 flogo.jpg GRAPHIC 6213
  Complete submission text file 0001437749-25-000865.txt   76423
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

EIN.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-284226 | Film No.: 25523651
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)